» Articles » PMID: 21142290

Intra-articular Injections for the Treatment of Osteoarthritis: Focus on the Clinical Use of Hyaluronic Acid

Overview
Journal Drugs R D
Specialty Pharmacology
Date 2010 Dec 15
PMID 21142290
Citations 46
Authors
Affiliations
Soon will be listed here.
Abstract

Osteoarthritis (OA), also called degenerative joint disease, is the most frequently occurring chronic musculoskeletal disease, particularly affecting the aging population. The use of viscosupplementation, i.e. intra-articular (IA) hyaluronic acid (HA) drug therapy, to treat OA, is growing worldwide, due to important results obtained from several clinical trials, which reported IA HA-related improvements in functional activity and pain management. This review is an update of the IA use of this compound in the treatment of OA, with clinical evidence from the last few years being discussed and used to delineate new trends for the future.

Citing Articles

The influence of natural polymers on loratadine's solubility and dissolution profiles.

Alkufi H, Ibrahim S, Hussein L J Med Life. 2024; 17(3):305-308.

PMID: 39044927 PMC: 11262610. DOI: 10.25122/jml-2023-0529.


Advancements in tissue engineering for articular cartilage regeneration.

Chen M, Jiang Z, Zou X, You X, Cai Z, Huang J Heliyon. 2024; 10(3):e25400.

PMID: 38352769 PMC: 10862692. DOI: 10.1016/j.heliyon.2024.e25400.


Effects of a Combination of Polynucleotide and Hyaluronic Acid for Treating Osteoarthritis.

Choi S, Kim H, Jang S, Lee Y, Heo J, Kweon G Int J Mol Sci. 2024; 25(3).

PMID: 38338992 PMC: 10855695. DOI: 10.3390/ijms25031714.


Comparing Intra-articular Platelet-Rich Plasma With Hyaluronic Acid for the Treatment of Hip Osteoarthritis: A Systematic Review and Meta-Analysis.

Sambe H, Yasir M, Man R, Gogikar A, Nanda A, Niharika Janga L Cureus. 2023; 15(10):e47919.

PMID: 37905161 PMC: 10613513. DOI: 10.7759/cureus.47919.


Hyaluronic acid/diminazene aceturate combination ameliorates osteoarthritic anomalies in a rodent model: a role of the ACE2/Ang1-7/MasR axis.

Habib Y, Sheta E, Khattab M, Gowayed M Inflammopharmacology. 2023; 31(6):3263-3279.

PMID: 37725260 PMC: 10692272. DOI: 10.1007/s10787-023-01335-5.


References
1.
Balazs E, Denlinger J . Viscosupplementation: a new concept in the treatment of osteoarthritis. J Rheumatol Suppl. 1993; 39:3-9. View

2.
Notoya K, Jovanovic D, Reboul P, Martel-Pelletier J, Mineau F, Pelletier J . The induction of cell death in human osteoarthritis chondrocytes by nitric oxide is related to the production of prostaglandin E2 via the induction of cyclooxygenase-2. J Immunol. 2000; 165(6):3402-10. DOI: 10.4049/jimmunol.165.6.3402. View

3.
Toole B . Hyaluronan in morphogenesis. Semin Cell Dev Biol. 2001; 12(2):79-87. DOI: 10.1006/scdb.2000.0244. View

4.
Nehrer S, Domayer S, Dorotka R, Schatz K, Bindreiter U, Kotz R . Three-year clinical outcome after chondrocyte transplantation using a hyaluronan matrix for cartilage repair. Eur J Radiol. 2005; 57(1):3-8. DOI: 10.1016/j.ejrad.2005.08.005. View

5.
Marshall K . Intra-articular hyaluronan therapy. Curr Opin Rheumatol. 2000; 12(5):468-74. DOI: 10.1097/00002281-200009000-00022. View